S. Jay Olshansky received his Ph.D. in Sociology/Demography at the University of Chicago in 1984. He is an Emeritus Professor in the School of Public Health at the University of Illinois at Chicago, Research Associate at the Center on Aging at the University of Chicago, former Chief Scientist at Lapetus Solutions, Inc. — a company that he co-founded, and former Chief Scientist at Wealthspan Financial Partners, LLC. The focus of his research is on estimates of the upper limits to human longevity, the health and public policy implications associated with individual and population aging, forecasts of the size, survival, and age structure of the population, pursuit of the scientific means to slow aging in people (The Longevity Dividend), and global implications of the re-emergence of infectious and parasitic diseases.

During the last 40 years, Dr. Olshansky has been working with colleagues in the biological sciences to develop the modern “biodemographic paradigm” of mortality – the biological nature of the survival and dying out processes of living organisms. Dr. Olshansky is the first author of The Quest for Immortality: Science at the Frontiers of Aging (Norton, 2001); A Measured Breath of Life (2013); The Rise of Generians (2020); Pursuing Wealthspan (2020); co-editor of Aging: The Longevity Dividend (Cold Spring Harbor Laboratory Press, 2015); and co-editor of Aging: Geroscience as the New Public Health Frontier (Cold Spring Harbor Laboratory Press, 2024).

Dr. Olshansky’s recent work is focused on linking the scientific study of aging with investments in longevity and mortality related products. Dr. Olshansky is a former Board member, American Federation of Aging Research (AFAR), U.S. Preventive Medicine, and he served on the Board of Scientific Advisors at PepsiCo. Dr. Olshansky has been honored with the Donald P. Kent Award from the Gerontological Society of America, the Irving S. Wright Award from the American Federation for Aging Research, he was named a Next Avenue Influencer in Aging; he received the Alvar Svanborg Award, the Glenn Award from the Glenn Foundation for Medical Research, the Kathy N. Johnson Achievement Award from Home Care Assistance, he was a Senior Fulbright Scholar in France, and was recognized by the Mayo Clinic with the George Randolph and Patricia Scott Visiting Professorship on the Physiology of Aging. In 2022 Dr. Olshansky testified before the U.S. House Committee on Science, Space, and Technology on the topic of aging and Geroscience and how advances in aging biology are about to transform what it means to grow old.